| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Takeda Pharmaceutical Co Ltd is a 10% Owner at OVID, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 51 sales. Those positions are worth an estimated $30.4M at current prices.
Our model assigns Takeda Pharmaceutical Co Ltd a strong insider score of 70/100, based on 40 past trades. Over a 12-month horizon, 87.5% of those trades were profitable, with an average 12-month return of +9.9%.
Takeda Pharmaceutical Co Ltd's largest disclosed position is in PHAT as 10% Owner, worth about $30.4M. The recent filings there lean toward selling, a net 4,916,417 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2024 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 3,703,703 | $8.10 | $29,999,994.30 | -49.7% | - | - | |
| Mar 14, 2022 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 18 | $19.00 | $342.00 | - | - | - | |
| Nov 4, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 1,000,001 | $20.85 | $20,850,019.00 | -90.9% | - | - | |
| Jul 7, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 2,609 | $35.05 | $91,445.45 | -0.3% | - | - | |
| Jul 2, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 8,326 | $35.16 | $292,727.16 | -0.9% | - | - | |
| Jun 28, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 24,501 | $35.49 | $869,427.36 | -2.7% | -4.5% | -76.2% | |
| Jun 24, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 11,048 | $35.14 | $388,198.72 | -1.2% | - | - | |
| Jun 22, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 9,394 | $35.31 | $331,671.14 | -1.0% | - | - | |
| Jun 18, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 8,703 | $35.11 | $305,571.14 | -0.9% | - | - | |
| Jun 14, 2021 | PHAT Phathom Pharmaceuticals, Inc. | 10% Owner | Sell | 2,826 | $35.06 | $99,079.56 | -0.3% | - | - |